ASTRAPHARM

Active Cambridge

Non-trading company

0 employees website.com
Non-trading company
A

ASTRAPHARM

Non-trading company

Founded 25 Apr 1953 Active Cambridge, United Kingdom 0 employees website.com
Non-trading company
Accounts Submitted 22 Apr 2025
Confirmation Submitted 20 Apr 2026 Next due 2 May 2027 12 months remaining
Net assets £13M £0 2024 year on year
Total assets £13M £0 2024 year on year
Total Liabilities £2K £0 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

1 Francis Crick Avenue Cambridge Biomedical Campus Cambridge CB2 0AA United Kingdom

Full company profile for ASTRAPHARM (00519037), an active company based in Cambridge, United Kingdom. Incorporated 25 Apr 1953. Non-trading company. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2014–2024)

Cash in Bank

N/A

Net Assets

£12.52M

Total Liabilities

£1.79k

Turnover

N/A

Employees

N/A

Debt Ratio

N/A

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

1 active 2 resigned
Status
Bowden, Matthew ShaunDirectorBritishEngland4827 Feb 2019Active

Shareholders

Shareholders (1)

Astrazeneca Continent B.v.
100.0%

Persons with Significant Control

Persons with Significant Control (1)

1 Active
Active
Notified 6 Apr 2016
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Group Structure

Group Structure

ASTRAPHARM Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
20 Apr 2026Confirmation StatementConfirmation statement made on 18 Apr 2026 with no updates
2 May 2025OfficersAppointment of Hannah Victoria Tattersall as director on 1 May 2025
1 May 2025OfficersTermination of Adrian Charles Noel Kemp as director on 1 May 2025
24 Apr 2025Confirmation StatementConfirmation statement made on 18 Apr 2025 with no updates
22 Apr 2025AccountsAnnual accounts made up to 31 Dec 2024
20 Apr 2026 Confirmation Statement

Confirmation statement made on 18 Apr 2026 with no updates

2 May 2025 Officers

Appointment of Hannah Victoria Tattersall as director on 1 May 2025

1 May 2025 Officers

Termination of Adrian Charles Noel Kemp as director on 1 May 2025

24 Apr 2025 Confirmation Statement

Confirmation statement made on 18 Apr 2025 with no updates

22 Apr 2025 Accounts

Annual accounts made up to 31 Dec 2024

Recent Activity

Latest Activity

Confirmation statement made on 18 Apr 2026 with no updates

1 weeks ago on 20 Apr 2026

Appointment of Hannah Victoria Tattersall as director on 1 May 2025

12 months ago on 2 May 2025

Termination of Adrian Charles Noel Kemp as director on 1 May 2025

12 months ago on 1 May 2025

Confirmation statement made on 18 Apr 2025 with no updates

1 years ago on 24 Apr 2025

Annual accounts made up to 31 Dec 2024

1 years ago on 22 Apr 2025